title: Existing evidence is insufficient to justify metformin or other agents as first-line therapy for type 2 diabetes.
authors.affiliation: Knowledge and Evaluation Research Unit, Mayo Clinic, Rochester, Minnesota, USA.|Division of Endocrinology, University Hospital 'Dr. Jose E. Gonzalez' Autonomous University of Nuevo Leon, Monterrey, Mexico.
authors.forename: Rene
authors.initials: R
authors.lastname: Rodriguez-Gutierrez
authors.affiliation: Knowledge and Evaluation Research Unit and Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic, Rochester, Minnesota, USA.
authors.forename: Victor M
authors.initials: VM
authors.lastname: Montori
mesh_terms: D003924:Diabetes Mellitus, Type 2; D006442:Glycated Hemoglobin; D006801:Humans; D007004:Hypoglycemic Agents; D008687:Metformin
chemical_list: D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D008687:Metformin